Clinical Trial Update: A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 study of haploidentical bone marrow transplantation for hematologic malignancies was terminated, with results posted on 2025-11-10.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: University of California, San Diego | Conditions: Hematologic Malignancies | Phase 2 | Status: TERMINATED | Results posted: 2025-11-10